Halozyme Therapeutics
HALO
#1868
Rank
ยฃ8.30 B
Marketcap
ยฃ72.86
Share price
-0.55%
Change (1 day)
35.85%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): ยฃ2.66

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is ยฃ2.67. In 2025 the company made an earnings per share (EPS) of ยฃ1.98 a decrease over its 2024 EPS that were of ยฃ2.66.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.6634.01%
2025ยฃ1.98-25.43%
2024ยฃ2.66
2022ยฃ1.12-48.07%
2021ยฃ2.16196.87%
2020ยฃ0.73-292%
2019-ยฃ0.38-9.09%
2018-ยฃ0.42-237.5%
2017ยฃ0.30-149.38%
2016-ยฃ0.61211.54%
2015-ยฃ0.20-52.73%
2014-ยฃ0.42-24.66%
2013-ยฃ0.5548.98%
2012-ยฃ0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.07 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.54-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.45 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.50-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ1.07-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-ยฃ0.09869-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA